Cong HU, Pan LI, Zhigang WANG, et al. Anti-ICAM targeted liposomes loaded with imatinib and liquid fluorocarbon treat ALI/ARDS mouse model induced by LPS[J]. Journal of Third Military Medical University, 2018, 40(15): 1357-1363.
DOI:
Cong HU, Pan LI, Zhigang WANG, et al. Anti-ICAM targeted liposomes loaded with imatinib and liquid fluorocarbon treat ALI/ARDS mouse model induced by LPS[J]. Journal of Third Military Medical University, 2018, 40(15): 1357-1363. DOI: 10.16016/j.1000-5404.201801166.
Anti-ICAM targeted liposomes loaded with imatinib and liquid fluorocarbon treat ALI/ARDS mouse model induced by LPS
To determine the therapeutic effect of intercellular cell adhesion molecule-1 (ICAM-1) targeted liposomes loaded with imatinib (IM) and liquid fluorocarbon (LF) on the treatment of lipopolysaccharides (LPS)-induced mouse model of acute lung injury/acute respiratory distress syndrome (ALI/ARDS).
Methods
2
The anti-ICAM-1 liposomes were prepared by rotary evaporation to load IM and LF
and the particle size was detected by Malvin particle size analyzer. Transmission electron microscopy was used to observe the loading of drugs in the liposomes
while under light microscopy for the shape of the prepared liposomes. Phase transformation was observed at constant temperature heating plate at 37.5℃
and release rate of the drugs from the liposomes was observed
in vitro
. A total of 30
6~8-week-old C57BL/6 mice were randomly divided into control group
LPS model group
and targeting ICAM-1 liposomes treatment group (
n
=10). In 1 d after the end of treatment
HE staining and immunofluorescence assay were employed to observe the morphology and distribution of ICAM-1 in the lung paraffin sections respectively. The mRNA levels of IL-6
IL-8
IL-10 and TNF-α in the lung tissue were detected by qRT-PCR. Pathological changes
wet-to-dry (W/D) lung weight ratio
and alveolar fluid clearance (AFC) were compared in the different groups. ICAM-1 targeted liposomes and non-targeted liposomes were injected into ALI/ARDS mice by tail vein. All organs were collected for frozen sections
and the distributions of the liposomes in various organs were observed
under confocal laser microscope.
Results
2
ICAM-1 targeted liposomes loaded with IM and LF were successfully prepared
with a particle size of 320.8±58.7 nm. Transmission electron microscopy displayed the drugs were successfully encapsulated inside them
while light microscopy showed the liposomes were uniform in size
and gradually formed into microbubbles at 37.5℃. The release of liposomes reached peak at 12 h
and the release curve of drugs was plotted. Compared with the control group
the mice of the LPS group presented typical pathological features of ALI/ARDS and obvious lung injury
and had increased pathological score (
P
<
0.01)
elevated IL-8
IL-6 and TNF-α levels (
P
<
0.01) while reduced IL-10 level (
P
<
0.05)
and increased W/D ratio (
P
<
0.01) and decreased AFC (
P
<
0.01). ICAM-1 targeted liposomes treatment obviously attenuated the lung injury
decreased pathological score (
P
<
0.05) and IL-8
IL-6 and TNF-α levels (
P
<
0.05)
but increased IL-10 level (
P
<
0.05)
reduced the W/D ratio of the lung (
P
<
0.05)
and improved AFC (
P
<
0.05).
Conclusion
2
ICAM-1 targeted liposomes loaded with IM and LF have obvious therapeutic effect on LPS-induced ALI/ARDS mice.
关键词
Keywords
references
BERNARD G R, ARTIGAS A, BRIGHAM K L, et al . The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination[J ] . Am J Respir Crit Care Med, 1994, 149(3 Pt 1):818-824. DOI:10.1164/ajrccm.149.3.7509706.
WARE L B, MATTHAY M A. The acute respiratory distress syndrome[J]. N Engl J Med, 2000, 342(18):1334-1349. DOI:10.1056/NEJM200005043421806.
CHISLOCK E M, RING C, PENDERGAST A M. Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survival[J]. Proc Natl Acad Sci USA, 2013, 110(30):12432-12437.DOI:10.1073/pnas.1304188110.
GREUBER E K, SMITH-PEARSON P, WANG J, et al . Role of ABL family kinases in cancer:from leukaemia to solid tumours[J ] . Nat Rev Cancer, 2013, 13(8):559-571. DOI:10.1038/nrc3563 .
MOEN M D, MCKEAGE K, PLOSKER G L, et al . Imatinib:a review of its use in chronic myeloid leukaemia[J ] . Drugs, 2007, 67(2):299-320. DOI:10.2165/00003495-200767020-00010.
RHEE C K, LEE S H, YOON H K, et al . Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice[J ] . Respiration, 2011, 82(3):273-287. DOI:10.1159/000327719.
AMAN J, PETERS M J, WEENINK C, et al . Reversal of vascular leak with imatinib[J ] . Am J Respir Crit Care Med, 2013, 188(9):1171-1173.DOI:10.1164/rccm.201301-0136LE.
DOS SANTOS L V, LIMA J P, ABDALLA K C, et al . Imatinib-induced bone edema:case report and review of literature[J ] . J Natl Compr Canc Netw, 2013, 11(10):1187-1191. DOI:10.6004/jnccn.2013.0140.
DRUKER B J, TALPAZ M, RESTA DJ, et al . Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia[J ] . N Engl J Med, 2001, 344(14):1031-1037. DOI:10.1056/NEJM200104053441401.
WANG Q, ZHENG X, CHENG Y, et al . Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na, K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury[J ] . J Immunol, 2014, 192(8):3765-3777. DOI:10.4049/jimmunol.1302421.
LIUJ Y, LYU X J, ZHAO W, et al .Sirt1 alleviated lipopolysaccharide damage in alveolar type Ⅱ epithelial cells by deacetylated NF-kappa B/p65 in[J ] .J Third Mil Med Univ, 2017, 39(14):1415-1421.DOI:10.16016/j.1000-5404.201611089.
LIANGJ N, ZHOU Q Q, ZHANG T X, et al . Changes of TNF-alpha and IL-1 beta in lung tissues of mice with acute respiratory distress syndrome and evaluation of[J ] . Cell Mol Immunol, 2017, 33(2):159-163. DOI:10.13423/j.cnki.cjcmi.008006.
WANGC J, XU F. Excessive autophagy on interleukin-1 beta in acute respiratory distresssyndrome in the comprehensive regulation of inflammatory effect[J]. J Chongqing Med Univ, 2017, 42(1):15-20.DOI:10.13406/j.cnki.cyxb.001144.
LETSIOU E, RIZZO A N, SAMMANI S, et al . Differential and opposing effects of imatinib on LPS-and ventilator-induced lung injury[J ] . Am J Physiol Lung Cell Mol Physiol, 2015, 308(3):L259-L269. DOI:10.1152/ajplung.00323.2014.
CHANDEL N S, BUDINGER G R, MUTLU G M, et al . Keratinocyte growth factor expression is suppressed in early acute lung injury/acute respiratory distress syndrome by smad and c-Abl pathways[J ] . Crit Care Med, 2009, 37(5):1678-1684. DOI:10.1097/CCM.0b013e 31819fc81a.
MITSOPOULOS P, OMRI A, ALIPOUR M, et al . Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents[J ] . Int J Pharm, 2008, 363(1/2):106-111.DOI:10.1016/j.ijpharm.2008.07.015.
STEIMBACH L M, TONIN F S, VIRTUOSO S, et al . Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis[J ] . Mycoses, 2017, 60(3):146-154. DOI:10.1111/myc.12585.
OLIVIER K N, GRIFFITH D E, EAG LE G, et al . Randomized trial of liposomal amikacin for inhalation in nontuberculous Mycobacterial lung disease[J ] . Am J Respir Crit Care Med, 2017, 195(6):814-823. DOI:10.1164/rccm.201604-0700OC.
MUZYKANTOV V R, CHRISTOFIDOU-SOLOMIDOU M, BALYASNIKOVA I, et al . Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1):a strategy for vascular immunotargeting of drugs[J ] . Proc Natl Acad Sci USA, 1999, 96(5):2379-2384. DOI:10.1073/pnas.96.5.2379.
BRENNER J S, BHAMIDIPATI K, GLASSMAN P M, et al . Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions[J ] . Nanomedicine, 2017, 13(4):1495-1506.DOI:10.1016/j.nano.2016.12.019.
Effect and mechanism of cryptotanshinone on early pulmonary fibrosis in LPS-induced acute respiratory distress syndrome in mice
Vitamin D alleviates lipopolysaccharide-induced acute lung injury in mice
Role and mechanism of SIRT3 in oxidative stress and mitochondrial biogenesis in alveolar type II cells
Preparation of doxorubicin-loaded polyphyllin H liposomes and synergistic anti-tumor activity against non-small cell lung cancer in vitro
Dexmedetomidine pretreatment enhances protective effect efficacy of pericytes agaist acute lung injury in septic mice
Related Author
张人子
李晟
王导新
李茜
赵燕
王导新
ZHOU Jun
LIU Yaojun
Related Institution
Department of Human Anatomy, Anhui Medical University
Department of Geriatrics and Special Service Medicine, First Affiliated Hospital(Southwest Hospital), Army Medical University (Third Military Medical University)
Institute of Field Surgery, Daping Hospital, Army Medical University
Laboratory of Stem Cell and Tissue Engineering, Chongqing Medical University
Department of Medical Service,No. Hospital of Joint Logistics Support Force